CLEC12A and COVID-19: The expression of CLEC12A was shown to be significantly lower in independent healthy control samples than in COVID-19 survivors or non-survivors at day 0 and day 7 (healthy controls vs. COVID-19 survivors: pday0 = 0.00097, pday7 = 0.00028; healthy controls vs. COVID-19 non-survivors: pday0 = 0.005, pday7 = 0.039; Supplementary Figure S3b, d).